Viewing Study NCT00500461

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:41 PM
Ignite Modification Date: 2026-01-17 @ 6:07 PM
Study NCT ID: NCT00500461
Status: COMPLETED
Last Update Posted: 2017-08-07
First Post: 2007-07-10
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study To Examine Safety, Tolerability And Pharmacokinetics Of Intravenous Doses And Oral Dose Of GSK233705
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pulmonary Disease, Chronic Obstructive View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Muscarinic Receptor Antagonist, View
None intravenous infusion, View
None pharmacokinetics View
None healthy subjects, View
None safety, View
None tolerability, View
None Anticholinergic, View
None oral dosing, View